SEC Filings | BioLineRx

Filing Date	Form	Description	View
Aug 19, 2020	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-20-002466.rtf 0001178913-20-002466.xls 0001178913-20-002466.pdf
Aug 12, 2020	EFFECT	EFFECT	9999999995-20-002112.rtf 9999999995-20-002112.xls 9999999995-20-002112.pdf
Aug 10, 2020	POS AM	Post-effective amendment to an S-Type filing	0001178913-20-002305.rtf 0001178913-20-002305.xls 0001178913-20-002305.pdf
Aug 06, 2020	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-20-002292.rtf 0001178913-20-002292.xls 0001178913-20-002292.pdf EX-101.INS - XBRL INSTANCE DOCUMENT
Jul 02, 2020	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	0001178913-20-001948.rtf 0001178913-20-001948.xls 0001178913-20-001948.pdf
Jul 02, 2020	EFFECT	EFFECT	9999999995-20-001641.rtf 9999999995-20-001641.xls 9999999995-20-001641.pdf
Jul 01, 2020	CORRESP	CORRESP	0001178913-20-001922.rtf 0001178913-20-001922.xls 0001178913-20-001922.pdf
Jul 01, 2020	UPLOAD	UPLOAD	0000000000-20-005902.rtf 0000000000-20-005902.pdf
Jun 26, 2020	F-1	Registration statement for certain foreign private issuers	0001178913-20-001877.rtf 0001178913-20-001877.xls 0001178913-20-001877.pdf
Jun 10, 2020	D	Notice of Exempt Offering of Securities	0001178913-20-001769.rtf 0001178913-20-001769.xls 0001178913-20-001769.pdf

Data provided by Kaleidoscope.